Nail Your Sales Interview with the 30/60/90 Day Sales Plan
If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.

Now you can nail your interview with the 30 60 90 Day Sales Plan template with Audio Coaching. This simple tool will help you knock the socks off your interviewer and bury your competition.

To get the details: Click Here

[Close Window]
Medical Sales Jobs Websites - the best Medical Sales Jobs | Laboratory Sales Jobs | Medical Device Sales Jobs

Posts on ‘December 4th, 2008’

New High Speed and High Resolution Micro CT to be Introduced Into North American Market

CHICAGO, ILLINOIS–Dec 4, 2008 — Dexas Pharmaceutical Sciences is very proud to have established a strategic alliance with V.A.M.P. (Erlangen, Germany) one of the pioneers of micro computed tomography development. Dexas will distribute V.A.M.P.’s TomoScope&re…
Devices, Radiology
Dexas Clinical Sciences, micro computed tomography, micro-CT, TomoScope

NovaRx Appoints Industry Veteran as President and COO

SAN DIEGO, Dec. 4 (HSMN NewsFeed) — NovaRx Corporation announced today the appointment of Norrie J.W. Russell, Ph.D to the career opportunity of President and Chief Operating Officer. Dr. Russell brings to the company more than 25 years experience in drug discove…
Biopharmaceuticals, Personnel
NovaRx

Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM)

DUBLIN, December 4 (HSMN NewsFeed) — Azur Pharma Limited ("Azur") today announced that it has entered into a definitive agreement with BioSante Pharmaceuticals, Inc ("BioSante")(Nasdaq: BPAX ) to acquire U.S. rights to Elestrin(TM). …
Biopharmaceuticals, Acquisitions
Azur Pharma, BioSante Pharmaceuticals, Elestrin, estradiol

Broncus Technologies Secures $38 Million in Funding Round Led by Ares Life Sciences

MOUNTAIN VIEW, CA–Dec 4, 2008 — Broncus Technologies, Inc., a medical device company developing products for emphysema and other lung diseases, announced today that it has closed a $38 million round of Series G funding, led by a $25 million investment fr…
Devices, Venture Capital
Broncus Technologies